Nurse-led virtual diabetes care with a smartphone app for adults on Medicaid and insulin
Official title: Nurse-led App Intervention to Improve Glycemic Control in Patients With Insulin-treated Type 2 Diabetes on Medicaid
Run by Rutgers, The State University of New Jersey · NCT06814184 · Data updated 2026-11-12
This 12-month pilot will test whether a nurse-led program using a smartphone app, MyChart messages, and phone coaching helps adults on Medicaid who have type 2 diabetes and use insulin better manage their blood sugar.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 2 sites (New Brunswick, New Jersey and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | December 1, 2028 |
| Study ends | December 1, 2028 |
| Registry record updated | July 2, 2026 |
| Trial ID | NCT06814184 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (18+) with type 2 diabetes who are on insulin, have an elevated A1C, are Medicaid or dual eligible, and can read English and use an Android or iOS smartphone.
✕Probably not a fit
Patients without a smartphone or smartphone skills, who are pregnant, have significant cognitive impairment, or do not read English are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Guided by the Self- and Family Management Framework, this 12-month pilot delivers a nurse-led, app-based behavioral program to Medicaid-enrolled adults with type 2 diabetes on insulin. The intervention combines MyChart education and goal-setting, a clinician–patient collaborative problem-solving action plan, and remote glucose monitoring via the mySugr app. Nurses provide messaging and phone-based support to reinforce self-management behaviors and identify when treatment adjustments may be needed. The study measures changes in self-management behaviors and glycemic control compared with usual care.
Why it matters
Potential benefit: If successful, the program could improve daily diabetes self-management and lower A1C for Medicaid patients by combining digital tracking with nurse support.
How similar studies have gone: Prior nurse-led and app-based remote-monitoring programs have shown modest improvements in self-management and A1C in some populations, but results vary and Medicaid groups have been less frequently studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A1C \>7 for age 18-64, A1C\>8 for age 65 or older within 12 months prior baseline * A1C\>7 for age 18-64, A1c\>8 for age 65 or older at baseline * Medicaid recipient or dual Medicaid and Medicare recipient * Age 18 or older * Type 2 diabetes * On insulin therapy * Owning and using Android or iOS smartphone for at least 6 months * English proficiency * Adequate vision to read text messages on their current smartphone * Smartphone use proficiency. Smartphone proficiency will be self-reported and determined by telephone as the ability to use a smartphone in ways other than emailing, texting, and making phone calls. Exclusion Criteria: * Pregnancy * Patients with cognitive impairment who will be screened with the Six-Item Screener to Identify Cognitive Impairment Among Potential Research Subjects.
Where it's running
-
Rutgers Health Family Medicine at Monument Square
New Brunswick, New Jersey, United States Recruiting -
University Medical Group General Internal Medicine
New Brunswick, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Helen NC Chen, PhD — Rutgers School of Nursing
- Study coordinator: Helen NC Chen, PhD
- Email: helen.nc.chen@rutgers.edu
- Phone: (908) 466-3953
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes
This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.